SM
HCAT icon

SCGE Management’s Health Catalyst HCAT Stock Holding History

SCGE Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-75,000
Closed -$1.96M – 26
2020
Q1 		$1.96M Hold
75,000
– – 0.06% 28
2019
Q4 		$2.6M Hold
75,000
– – 0.11% 22
2019
Q3 		$2.37M Buy
+75,000
New +$2.95M 0.12% 23

Other funds holding HCAT

NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SCGE Management's HCAT Position: Q2 2020 in Review

SCGE Management sold out of Health Catalyst (HCAT) in Q2 2020, closing a stake of 75,000 shares — an estimated $1.96M sold.

SCGE Management first reported a position in HCAT in Q3 2019 and held it in 3 quarters. The position peaked at $2.6M in Q4 2019. 128 funds tracked by Wall St. Rank hold HCAT as of Q2 2020.

  • SCGE Management reported no remaining Health Catalyst position as of Q2 2020 after selling out during the quarter.
  • SCGE Management sold 75,000 Health Catalyst shares in Q2 2020, an estimated $1.96M.
  • SCGE Management first reported a position in Health Catalyst in Q3 2019 and held it in 3 quarters.
  • SCGE Management's Health Catalyst position peaked at $2.6M in Q4 2019.
  • 128 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2020.

Based on SCGE Management's 13F filing for Q2 2020, filed 14 Aug 2020.